Dr Donald Lee Weaver, MD | |
111 Colchester Ave, Burlington, VT 05401-1473 | |
(802) 847-3566 | |
(802) 847-9644 |
Full Name | Dr Donald Lee Weaver |
---|---|
Gender | Male |
Speciality | Pathology |
Experience | 40 Years |
Location | 111 Colchester Ave, Burlington, Vermont |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215959630 | NPI | - | NPPES |
0009728 | Medicaid | VT | |
01192649 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 042-0007578 (Vermont) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has entered into an agreement and plan of merger with Decade Sunshine Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands, and Decade Sunshine Merger Sub, an exempted company with limited liability incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of Parent.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.
Asthma is the most common chronic illness affecting Latino children in the United States, and secondhand smoke is a serious contributing factor. Now a new study from The Miriam Hospital's Centers for Behavioral and Preventive Medicine and Brown University suggests that clinically-based smoking cessation programs may not be enough to help Latino smokers with asthmatic children kick the habit.
QIAGEN announced today the CE-IVD marking of its novel liquid biopsy-based companion diagnostic that analyzes circulating nucleic acids obtained from blood samples to assess an important genomic mutation in patients with non-small cell lung cancer (NSCLC), the most common form of this cancer.
› Verified 3 days ago
Entity Name | University Of Vermont Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has entered into an agreement and plan of merger with Decade Sunshine Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands, and Decade Sunshine Merger Sub, an exempted company with limited liability incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of Parent.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.
Asthma is the most common chronic illness affecting Latino children in the United States, and secondhand smoke is a serious contributing factor. Now a new study from The Miriam Hospital's Centers for Behavioral and Preventive Medicine and Brown University suggests that clinically-based smoking cessation programs may not be enough to help Latino smokers with asthmatic children kick the habit.
QIAGEN announced today the CE-IVD marking of its novel liquid biopsy-based companion diagnostic that analyzes circulating nucleic acids obtained from blood samples to assess an important genomic mutation in patients with non-small cell lung cancer (NSCLC), the most common form of this cancer.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Donald Lee Weaver, MD 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-3566 | Dr Donald Lee Weaver, MD 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-3566 |
News Archive
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has entered into an agreement and plan of merger with Decade Sunshine Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands, and Decade Sunshine Merger Sub, an exempted company with limited liability incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of Parent.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.
Asthma is the most common chronic illness affecting Latino children in the United States, and secondhand smoke is a serious contributing factor. Now a new study from The Miriam Hospital's Centers for Behavioral and Preventive Medicine and Brown University suggests that clinically-based smoking cessation programs may not be enough to help Latino smokers with asthmatic children kick the habit.
QIAGEN announced today the CE-IVD marking of its novel liquid biopsy-based companion diagnostic that analyzes circulating nucleic acids obtained from blood samples to assess an important genomic mutation in patients with non-small cell lung cancer (NSCLC), the most common form of this cancer.
› Verified 3 days ago
Dr. Laura Aman Greene, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Ep-2-113, Burlington, VT 05401 Phone: 802-847-3566 Fax: 802-847-4155 | |
Dr. Pamela Cox Gibson, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-3989 Fax: 802-847-9644 | |
Dr. Mark K Fung, MD, PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Fletcher Allen Health Care - Pathology, Burlington, VT 05401 Phone: 802-847-3000 Fax: 802-847-3509 | |
Dr. Nicholas Jackson Hardin, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2795 Fax: 802-847-9644 | |
Dr. Siba El Hussein, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-5121 | |
Ms. Allison Leigh Ciolino, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-5121 | |
Dr. John H Lunde, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Fletcher Allen Health Care, Pathology, Burlington, VT 05401 Phone: 802-847-5135 Fax: 802-847-3987 |